US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
KR0162872B1
(ko)
*
|
1996-04-01 |
1998-12-01 |
김은영 |
용매추출법을 이용한 생분해성 고분자 미립구의 개선된 제조방법 및 이를 이용한 국소염증 질환 치료용 미립구의 제조방법
|
KR100236771B1
(ko)
*
|
1997-04-01 |
2000-02-01 |
성재갑 |
히아루론산을 이용한 약물의 서방성 미세입자 제형
|
US7276251B2
(en)
*
|
1997-04-01 |
2007-10-02 |
Lg Life Sciences, Ltd., Inc. |
Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
|
TW586934B
(en)
*
|
1997-05-19 |
2004-05-11 |
Sumitomo Pharma |
Immunopotentiating composition
|
US6156347A
(en)
*
|
1998-01-21 |
2000-12-05 |
Bio-Dar Ltd. |
Controlled release chromium picolinate
|
US7087236B1
(en)
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
GB9819272D0
(en)
*
|
1998-09-03 |
1998-10-28 |
Andaris Ltd |
Microparticles
|
KR100359252B1
(ko)
*
|
1999-12-21 |
2002-11-04 |
주식회사 엘지생명과학 |
항원을 포함하는 고체상 미세입자 및 이를 포함하는 제제
|
BR0004152A
(pt)
|
1999-01-18 |
2000-11-21 |
Lg Chemichal Ltd |
Micropartìculas lipófilas contendo um medicamento protéico ou antìgeno e preparado compreendendo o mesmo
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
US6432448B1
(en)
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
EP1218001B1
(en)
*
|
1999-09-03 |
2008-12-31 |
Sigma-Tau Healthscience S.p.A. |
Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
GB0000891D0
(en)
*
|
2000-01-14 |
2000-03-08 |
Allergy Therapeutics Ltd |
Formulation
|
CN1242750C
(zh)
*
|
2000-02-08 |
2006-02-22 |
分子农业生物学院 |
可生物降解的且生物相容的封装有肠炎沙门氏菌的聚合物微球体
|
US6375972B1
(en)
*
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
GB0017999D0
(en)
*
|
2000-07-21 |
2000-09-13 |
Smithkline Beecham Biolog |
Novel device
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
SE517422C2
(sv)
*
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Farmaceutiskt acceptabel stärkelse
|
SE517421C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
|
AU2001294459A1
(en)
|
2000-10-06 |
2002-04-15 |
Jagotec Ag |
A controlled-release, parenterally administrable microparticle preparation
|
SE518008C2
(sv)
*
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Parenteralt administrerbara mikropartiklar och förfarande för framställning av desamma
|
SE518007C2
(sv)
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Förfarande för framställning av mikropartiklar
|
TR200300731T2
(tr)
|
2000-11-28 |
2004-08-23 |
Fmc Corporation |
Yenebilir PGA kaplama bileşimi
|
US20070142325A1
(en)
*
|
2001-01-08 |
2007-06-21 |
Gustavsson Nils O |
Starch
|
EP2545937A1
(en)
*
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
US7030127B2
(en)
*
|
2001-06-29 |
2006-04-18 |
Ethicon, Inc. |
Composition and medical devices utilizing bioabsorbable polymeric waxes
|
US7034037B2
(en)
*
|
2001-06-29 |
2006-04-25 |
Ethicon, Inc. |
Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
|
US6967234B2
(en)
*
|
2002-12-18 |
2005-11-22 |
Ethicon, Inc. |
Alkyd-lactone copolymers for medical applications
|
US7105181B2
(en)
*
|
2001-10-05 |
2006-09-12 |
Jagotec, Ag |
Microparticles
|
SE0201599D0
(sv)
*
|
2002-03-21 |
2002-05-30 |
Skyepharma Ab |
Microparticles
|
US7326426B2
(en)
*
|
2002-03-29 |
2008-02-05 |
Ethicon, Inc. |
Compositions and medical devices utilizing bioabsorbable liquid polymers
|
US7005136B2
(en)
|
2002-03-29 |
2006-02-28 |
Ethicon, Inc. |
Bone replacement materials utilizing bioabsorbable liquid polymers
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
KR100479735B1
(ko)
*
|
2002-05-25 |
2005-03-30 |
이현철 |
대식세포특이 나노입자-면역조절제-면역원 복합체를이용한 치아우식증을 예방하는 비경구용 백신
|
US7368125B2
(en)
*
|
2002-06-05 |
2008-05-06 |
Ethicon, Inc. |
Amphiphilic polymers for medical applications
|
US7026374B2
(en)
*
|
2002-06-25 |
2006-04-11 |
Aruna Nathan |
Injectable microdispersions for medical applications
|
US7101566B2
(en)
*
|
2002-06-28 |
2006-09-05 |
Ethicon, Inc. |
Polymer coated microparticles for sustained release
|
FR2842737B1
(fr)
*
|
2002-07-25 |
2006-01-27 |
Centre Nat Rech Scient |
Particules revetues en surface de hyaluronane ou d'un de ses derives et leur utilisation a titre de vecteurs biologiques pour des matieres actives
|
US20040047835A1
(en)
*
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
US6872799B2
(en)
|
2002-12-18 |
2005-03-29 |
Ethicon, Inc. |
Functionalized polymers for medical applications
|
US6866860B2
(en)
|
2002-12-19 |
2005-03-15 |
Ethicon, Inc. |
Cationic alkyd polyesters for medical applications
|
CA2510319A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Thomas J. Smith |
High pressure compaction for pharmaceutical formulations
|
US20040120981A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Aruna Nathan |
Crosslinked alkyd polyesters for medical applications
|
US7446131B1
(en)
*
|
2004-06-10 |
2008-11-04 |
The United States Of America As Represented By The Secretary Of Agriculture |
Porous polymeric matrices made of natural polymers and synthetic polymers and optionally at least one cation and methods of making
|
WO2006059846A1
(en)
*
|
2004-12-01 |
2006-06-08 |
Lg Life Sciences, Ltd. |
Formulation of sec1 mutated protein and method for formulation of the same
|
EP1726299A3
(en)
*
|
2005-05-27 |
2007-04-18 |
StratoSphere Pharma AB |
Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
|
EP1926780B1
(en)
|
2005-09-22 |
2013-08-14 |
Medivas, LLC |
Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
|
CA2623239C
(en)
*
|
2005-09-22 |
2016-07-12 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
JP2009518289A
(ja)
*
|
2005-11-21 |
2009-05-07 |
メディバス エルエルシー |
高分子の送達用ポリマー粒子および使用方法
|
WO2007067744A2
(en)
*
|
2005-12-07 |
2007-06-14 |
Medivas, Llc |
Method for assembling a polymer-biologic delivery composition
|
EP2019645A4
(en)
*
|
2006-05-02 |
2013-03-06 |
Medivas Llc |
RELEASE OF OPHTHALMOLOGICAL ACTIVITIES OUTSIDE OR WITHIN THE EYE
|
JP5196498B2
(ja)
*
|
2006-05-09 |
2013-05-15 |
メディバス エルエルシー |
生分解性水溶性ポリマー
|
CA2709412A1
(en)
*
|
2007-07-24 |
2009-01-29 |
Medivas, Llc |
Biodegradable cationic polymer gene transfer compositions and methods of use
|
CA2826508C
(en)
*
|
2008-05-23 |
2016-07-19 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
EP2323671A4
(en)
*
|
2008-08-13 |
2012-09-26 |
Medivas Llc |
BIODEGRADABLE AABB POLY (DEPSIPEPTIDE) POLYMERS AND METHOD FOR THEIR USE
|
MX2011003277A
(es)
*
|
2008-10-14 |
2012-09-21 |
Salubrious Pharmaceuticals LLC |
Proceso para el tratamiento de la artritis reumatoide, temblores/enfermedad de parkinson, esclerosis multiple y cancer de tipo no viral.
|
US8551505B2
(en)
*
|
2008-10-31 |
2013-10-08 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9050070B2
(en)
*
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8545857B2
(en)
*
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US8731840B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8603494B2
(en)
*
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US20100111857A1
(en)
|
2008-10-31 |
2010-05-06 |
Boyden Edward S |
Compositions and methods for surface abrasion with frozen particles
|
US8725420B2
(en)
*
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8788211B2
(en)
*
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
|
US9072688B2
(en)
*
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8485861B2
(en)
*
|
2008-10-31 |
2013-07-16 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
US9072799B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9050317B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US20100111834A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Compositions and methods for therapeutic delivery with frozen particles
|
US8409376B2
(en)
|
2008-10-31 |
2013-04-02 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8603495B2
(en)
*
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US9050251B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8731841B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060934B2
(en)
*
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9060931B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8731842B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US8762067B2
(en)
*
|
2008-10-31 |
2014-06-24 |
The Invention Science Fund I, Llc |
Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
|
US8721583B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8793075B2
(en)
|
2008-10-31 |
2014-07-29 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060926B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8545855B2
(en)
*
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8798933B2
(en)
*
|
2008-10-31 |
2014-08-05 |
The Invention Science Fund I, Llc |
Frozen compositions and methods for piercing a substrate
|
CN102596243B
(zh)
*
|
2009-06-16 |
2015-10-21 |
密执安大学评议会 |
纳米乳剂疫苗
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
JP5805195B2
(ja)
|
2010-08-23 |
2015-11-04 |
カンステム バイオテック カンパニー リミテッド |
Nod2アゴニストで処理した幹細胞またはその培養物を含む免疫疾患および炎症性疾患の予防および治療用の薬学的組成物
|
WO2012082765A2
(en)
|
2010-12-16 |
2012-06-21 |
The United State Of America. As Represented By The Secretary Department Of Health And Human Services |
Methods for decreasing body weight and treating diabetes
|
CA2830600C
(en)
|
2011-03-23 |
2021-07-27 |
Tomokazu AMANO |
Compositions and methods for enhancing the pluripotency of stem cells
|
WO2012142160A1
(en)
|
2011-04-12 |
2012-10-18 |
Rigel Pharmaceuticals, Inc. |
Methods for inhibiting allograft rejection
|
JP6189829B2
(ja)
|
2011-05-13 |
2017-08-30 |
ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンティド・バイ・ザ・セクレタリー・フォー・ザ・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシズ |
Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化
|
EP2723801B1
(en)
|
2011-06-23 |
2017-01-18 |
DSM IP Assets B.V. |
New biodegradable polyesteramide copolymers for drug delivery
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
JP6099098B2
(ja)
*
|
2011-11-17 |
2017-03-22 |
国立大学法人富山大学 |
生理活性物質徐放制御組成物
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
KR20220011805A
(ko)
|
2013-03-15 |
2022-01-28 |
엘릭서젠 쎄라퓨틱스, 인크. |
인간 세포를 회춘시키기 위한 zscan4의 사용 방법
|
BR112015024234B1
(pt)
|
2013-03-21 |
2022-11-16 |
Eupraxia Pharmaceuticals USA LLC |
Composição farmacêutica de liberação sustentada injetável, uso da mesma para diminuir inflamação ou controlar dor e método para formar micropartículas revestidas
|
AU2014248090B2
(en)
|
2013-04-03 |
2018-08-02 |
N-Fold Llc |
Novel nanoparticle compositions
|
CN105338961A
(zh)
*
|
2013-05-22 |
2016-02-17 |
Ucb生物制药私人有限公司 |
制备包含治疗性蛋白质的颗粒的方法
|
EP2805708A1
(en)
*
|
2013-05-22 |
2014-11-26 |
UCB Pharma, S.A. |
Methods to produce particles comprising therapeutic proteins
|
AU2014340241B2
(en)
|
2013-10-21 |
2018-11-01 |
Salk Institute For Biological Studies |
Mutated fibroblast growth factor (FGF) 1 and methods of use
|
JP6625071B2
(ja)
|
2014-03-07 |
2019-12-25 |
ザ アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ |
慢性疼痛用のナトリウムチャネルを標的とする非麻薬性crmp2ペプチド
|
WO2016097297A1
(en)
|
2014-12-18 |
2016-06-23 |
Dsm Ip Assets B.V. |
Drug delivery system for delivery of acid sensitive drugs
|
DK3206672T3
(en)
|
2015-10-27 |
2018-06-18 |
Eupraxia Pharmaceuticals Inc |
Formulations for sustained release of local anesthetics
|
WO2018160772A1
(en)
|
2017-02-28 |
2018-09-07 |
The United State Of America, As Represented By The Secretary, Department Of Health & Human Services |
Method of treating obesity, insulin resistance, non-alcoholic fatty liver disease including non-alcoholic steatohepatitis
|
CN107375921B
(zh)
*
|
2017-06-12 |
2019-10-29 |
商丘美兰生物工程有限公司 |
一种甘草皂苷脂质体免疫佐剂及其制备方法
|
CA3094345A1
(en)
|
2018-04-12 |
2019-10-17 |
Krystal Biotech, Inc. |
Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
|
WO2020068862A1
(en)
|
2018-09-24 |
2020-04-02 |
Krystal Biotech, Inc. |
Compositions and methods for the treatment of netherton syndrome
|
EP3856914A1
(en)
|
2018-09-26 |
2021-08-04 |
Krystal Biotech, Inc. |
Compositions and methods for the treatment of skin diseases
|
MX2021008832A
(es)
|
2019-02-08 |
2021-09-08 |
Krystal Biotech Inc |
Composiciones y metodos para la administracion de polipeptidos cftr.
|
WO2020186187A1
(en)
|
2019-03-13 |
2020-09-17 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods for treating bladder and urethra dysfunction and disease
|
CA3149164A1
(en)
|
2019-09-03 |
2021-03-11 |
Suma Krishnan |
Compositions and methods for the treatment of congenital ichthyoses
|
JP2023507989A
(ja)
|
2019-12-20 |
2023-02-28 |
クリスタル バイオテック インコーポレイテッド |
気道及び/または肺への遺伝子送達のための組成物及び方法
|
US20230181672A1
(en)
|
2020-05-07 |
2023-06-15 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms
|
BR112023020209A2
(pt)
|
2021-04-02 |
2023-12-19 |
Krystal Biotech Inc |
Genoma do vírus do herpes recombinante, vírus do herpes, composição farmacêutica, uso do vírus do herpes ou da composição farmacêutica, método para expressar, realçar, aumentar, ampliar e/ou suplementar os níveis de um polipeptídeo imunomodulatório, método para prover alívio profilático, paliativo ou terapêutico, e, método para tratar câncer
|
WO2024182707A1
(en)
|
2023-03-02 |
2024-09-06 |
Krystal Biotech, Inc. |
Interleukin-2 and interleukin-12 for cancer therapy
|